Russian scientists have found the Sputnik V vaccine 97.6 per cent effective against Covid-19 in a “real-world” assessment based on data from 3.8 million people, Moscow's Gamaleya Institute and the Russian Direct Investment Fund said on Monday.
The new effectiveness rate is higher than the 91.6 per cent rate outlined in results from a large-scale trial of Sputnik V that was published in The Lancet medical journal earlier this year, and compares favourably with data on the effectiveness of other Covid vaccines.
The new data was based on 3.8 million Russians who received both a first shot and a booster shot as part of the national roll-out of Sputnik V.
“This data confirms that Sputnik V demonstrates one of the best protection rates against coronavirus among all vaccines,” said Kirill Dmitriev, head of the RDIF sovereign wealth fund which is backing the vaccine. The incidence of infection was calculated from the 35th day from the first injection, the statement said, showing an incidence rate of 0.027 per cent. The incidence of infection among unvaccinated adults during a considerable period following the launch of mass vaccination in Russia was 1.1 per cent, it said, without specifying the date range used. The new data will be published in a peer-reviewed medical journal next month.
The data was collated from a database kept by the health ministry that registers vaccinated people, as well as a separate database of people who were infected with Covid-19 in the country.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU